NFKB1 and cancer: However, the general positive anti-tumor effect induced by NF-κB in DCs may be a contradiction to the negative effect of inflammation induced by NF-κB in the immune microenvironment such as TAMs and Treg, which shed light on tipping the nuanced balance in the therapy of cancer.